Understanding how the tectorial membrane develops and functions in hearing.
Molecular mechanisms underlying morphogenesis of the tectorial membrane
This study is looking at how certain proteins help build a key part of the inner ear that is important for hearing, which could help us understand why some people have hearing loss as they get older and lead to new treatments for it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11012891 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms that contribute to the formation and organization of the tectorial membrane, a crucial structure in the inner ear responsible for sound processing. By examining how specific proteins, particularly TECTA, interact and contribute to the architecture of this membrane, the study aims to uncover the underlying causes of hereditary hearing deficits. The research employs in vitro assays to analyze the dynamics of these proteins and their role in the maturation of the tectorial membrane. Patients with age-related hearing loss may benefit from insights gained through this research, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing age-related hearing loss or hereditary hearing deficits.
Not a fit: Patients with hearing loss due to non-genetic factors or those without any hearing impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for age-related hearing loss.
How similar studies have performed: While the specific molecular mechanisms of the tectorial membrane are not extensively studied, related research in auditory biology has shown promise in understanding hearing loss.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Park, Sung Jin — University of Utah
- Study coordinator: Park, Sung Jin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.